ACET - CIK 0001720580
The table below shows Adicet Bio, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $17.49M | $22.85M | $28.42M | $22.81M | $26.25M | $25.90M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $4.08M |
| $5.10M |
| $3.97M |
| $7.07M |
| $6.90M |
| $6.95M |
| Operating income | -$21.57M | -$27.95M | -$32.39M | -$29.89M | -$33.15M | -$32.85M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$20.24M | -$26.86M | -$31.22M | -$28.21M | -$30.48M | -$29.90M |
| EPS (diluted) | -$1.88 | -$0.29 | -$0.34 | -$4.96 | -$0.34 | -$0.33 |